The global enteral feeding formulas market size was estimated at USD 7.64 billion in 2024 and is projected to reach USD 10.52 billion by 2030, growing at a CAGR of 5.43% from 2025 to 2030. This growth is primarily driven by the increasing prevalence of chronic diseases such as cancer, stroke, multiple sclerosis, dementia, chronic liver disease, chronic obstructive pulmonary disease (COPD), and diabetes, which often lead to difficulties in oral intake and necessitate nutritional support through enteral feeding formulas.

According to data published by the Centers for Disease Control and Prevention (CDC) in February 2024, approximately 34.2 million individuals are living with diabetes in the U.S., and more than 1.5 million new cases are diagnosed every year. This highlights the growing need for effective nutritional management solutions for patients with metabolic disorders.

Sarcopenia—a condition characterized by a loss of muscle mass, strength, and function—is another significant contributor to the demand for enteral nutrition. It is commonly associated with aging, and its dietary management often requires the use of enteral feeding products. An article published in BioMed Central in December 2022 reported that the prevalence of sarcopenia ranges from 1% to 29% among older adults and is even higher among patients receiving long-term care. The study also emphasized that malnutrition and sarcopenia frequently overlap in elderly individuals, with those at risk of malnutrition being more susceptible to sarcopenia.

Enteral nutrition plays a crucial role in both preventing and managing aging-related sarcopenia. Consequently, the growing geriatric population, along with the rising incidence of age-associated chronic diseases and health complications, is expected to significantly drive the expansion of the enteral feeding formulas market over the forecast period.

Key Market Trends & Insights:

• North America dominated the enteral feeding formulas market with the largest revenue share of 30.85% in 2024. The region’s strong position can be attributed to the high prevalence of chronic and lifestyle-related diseases, growing elderly population, and well-established healthcare infrastructure that supports the widespread use of enteral nutrition. Furthermore, favorable reimbursement policies and the growing awareness regarding the importance of clinical nutrition among patients and healthcare professionals have contributed to regional market expansion.

• The enteral feeding formulas market in the U.S. is experiencing robust growth, driven by increasing cases of chronic conditions such as cancer, neurological disorders, and gastrointestinal diseases, which often require enteral nutritional support. In addition, advancements in healthcare technology, coupled with the presence of leading market players and continuous product innovations, are further strengthening the country’s market position.

• Based on product, the standard formula segment led the market with the largest revenue share of 53.7% in 2024. This dominance is due to the wide availability of standard formulas, their cost-effectiveness, and suitability for patients who can digest and absorb nutrients normally but are unable to consume adequate nutrition orally. These formulas are commonly used across hospitals and home care settings, supporting steady demand.

• Based on flow type, the intermittent feeding flow segment accounted for the largest revenue share in 2024. The growing preference for intermittent feeding is attributed to its physiological benefits, such as improved nutrient absorption and reduced gastrointestinal discomfort. This feeding method also provides greater flexibility for patients, making it suitable for both clinical and home care environments.

• Based on end user, the home care segment accounted for the largest market revenue share in 2024. This trend is primarily driven by the growing emphasis on patient comfort, the increasing availability of portable enteral feeding equipment, and the rising adoption of home-based care services. Additionally, the cost-effectiveness and convenience of home enteral feeding compared to hospital-based care have further supported the growth of this segment.

Order a free sample PDF of the Enteral Feeding Formulas Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 7.64 Billion

• 2030 Projected Market Size: USD 10.52 Billion

• CAGR (2025-2030): 5.43%

• North America: Largest market in 2024

• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

Some of the key market players operating in the enteral feeding formulas industry include Abbott, Danone S.A., Fresenius Kabi AG, Nestlé, Meiji Holdings, and Mead Johnson & Company, LLC. These companies play a crucial role in shaping the global market through continuous innovation, product development, and strategic initiatives aimed at strengthening their market position and expanding their consumer base.

To maintain a competitive edge, these market leaders focus on strategies such as new product launches, portfolio diversification, partnerships, and technological advancements in enteral nutrition. Their emphasis lies in catering to the evolving nutritional needs of patients while aligning with emerging trends such as organic and plant-based formulations.

For instance, in September 2021, Abbott took a significant step toward addressing the growing global demand for healthier enteral nutrition solutions by introducing plant-based protein and organic food ingredients in its product lines. The company relaunched PediaSure Harvest and introduced Ensure Harvest, both designed to provide nutrient-rich, organic options for individuals requiring specialized nutrition support. This initiative reflects Abbott’s commitment to sustainability, clean-label nutrition, and meeting the dietary preferences of modern consumers while ensuring high-quality clinical outcomes.

Through such initiatives, leading players continue to strengthen their foothold in the enteral feeding formulas market, driving innovation and promoting the adoption of safer, more effective nutritional solutions worldwide.

Key Players

• Abbott

• Danone S.A

• Fresenius Kabi AG

• Nestlé

• VICTUS

• Primus Pharmaceuticals, Inc.

• Meiji Holdings. Co., Ltd.

• Mead Johnson & Company, LLC

• Alcresta Therapeutics

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The enteral feeding formulas market is poised for steady growth, driven by the rising prevalence of chronic diseases, increasing geriatric population, and greater demand for nutritional support in both hospital and home-care settings. Advances in product development—particularly standard and disease-specific formulas—and a shift toward home-based nutrition are shaping the market’s trajectory. Regional dominance in developed markets and growing opportunities in emerging economies further underscore its long-term potential.